Mechanism of thymidine incorporation into acid insoluble fraction via nucleoside transporters on oxidative stress DNA injury
-
- Tanaka Koh-ichi
- Division of Pharmacology, Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Japan Department of Pharmacology, Hyogo College of Medicine, Japan Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
-
- Kitanaka Nobue
- Department of Pharmacology, Hyogo College of Medicine, Japan
-
- Kitanaka Junichi
- Department of Pharmacology, Hyogo College of Medicine, Japan
-
- Tomita Kazuo
- Division of Pharmacology, Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Japan Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
-
- Tsukahara Takao
- Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
-
- Sato Tomoaki
- Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
-
- Takemura Motohiko
- Department of Pharmacology, Hyogo College of Medicine, Japan
-
- Nishiyama Nobuyoshi
- Division of Pharmacology, Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Japan
抄録
<p>We have found that cultured astrocytes pretreated with N6, 2'-O-dibutyryladenosine 3',5'-cyclic monophosphate (DBcAMP), a permeable analogue of cAMP, but not astrocytes pretreated without DBcAMP and neurons, have the ability to incorporate thymidine into acid insoluble fraction via nucleoside transporters at an early time for repair on hydrogen peroxide (H2O2)-induced DNA injury.</p><p>We studied expression of equilibrative nucleoside transporter (ENT) and concentrative nucleoside transporter (CNT) and the relation between thymidine incorporation into intracellular spaces (membrane transport) and acid insoluble fraction (DNA repair) on cultured astrocytes pretreated with DBcAMP in the presence and absence of H2O2. We concerned that astrocytes express ENT1, ENT2, and CNT2, CNT3, but not CNT1, by western blot, immunocytochemistry and RT-PCR, and H2O2 caused decrease in membrane transport of thymidine from extracellular spaces to intracellular spaces and increase in incorporation of thymidine into acid insoluble fraction to cultured astrocytes pretreated with DBcAMP.</p><p>These finding indicate that cultured differentiated astrocytes could incorporate thymidine effectively into acid insoluble fraction for repair on H2O2-induced DNA injury, although the function of ENT2 and CNT3 might be impaired.</p>
収録刊行物
-
- 日本薬理学会年会要旨集
-
日本薬理学会年会要旨集 WCP2018 (0), PO4-1-86-, 2018
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390848647547558016
-
- NII論文ID
- 130007902002
-
- ISSN
- 24354953
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可